Delivery Order SPE2DB22D1103-SPE2DB24FTMU2
Award Date
6/26/24
Potential Completion Date
6/27/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,870.81, is for the delivery of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product, with a completion date of November 8, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $14,027.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a completion date of May 30, 2025. This is a firm fixed-price delivery order contract, which is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $6,598.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a period of performance through April 18, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $2,258.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a period of performance through May 9, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $3,333.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a completion date of March 26, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, valued at $3,566.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a performance period ending on May 1, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,187.36 delivery order contract is for the supply of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,505.68, is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, with an ultimate completion date of April 7, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. This contract award is not associated with a set-aside designation....
This federal contract award, valued at $1,972.67, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, to support military treatment facilities and federal healthcare programs. The contract has an ultimate completion date of July 25, 2024 and is a firm fixed-price delivery order with no...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,257.78, is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, and has an ultimate completion date of November 5, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...